Literature DB >> 29607300

Do Statins Induce or Protect from Acute Kidney Injury and Chronic Kidney Disease: An Update Review in 2018.

An Verdoodt1, Patrick M Honore2, Rita Jacobs1, Elisabeth De Waele1, Viola Van Gorp1, Jouke De Regt1, Herbert D Spapen1.   

Abstract

Statins essentially are cholesterol-lowering drugs that are extensively prescribed for primary and secondary prevention of cardiovascular disease. Compelling evidence suggests that the beneficial effects of statins may not only be due to its ability to control cholesterol levels but also due to a pleiotropic cholesterol-independent anti-inflammatory, antioxidant, endothelial-protective and plaque-stabilizing activity. Along this line, statins may also exert acute and long-term effects on renal function. We present a narrative literature review that summarizes arguments in favor of or against the preventive and/or therapeutic use of statins in kidney-related diseases or complications. We also highlight the ongoing controversy regarding statin therapy in chronic and end-stage kidney disease.

Entities:  

Keywords:  acute kidney injury; cardiorenal syndrome; chronic kidney disease; contrast-induced nephropathy; end-stage renal disease; rhabdomyolysis; statins

Year:  2018        PMID: 29607300      PMCID: PMC5874483          DOI: 10.2478/jtim-2018-0005

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN: 2224-4018


  41 in total

1.  HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Authors:  Cássio José de Oliveira Rodrigues
Journal:  Sao Paulo Med J       Date:  2015 Nov-Dec       Impact factor: 1.044

2.  A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes.

Authors:  Giancarlo Marenzi; Nicola Cosentino; José P Werba; Calogero C Tedesco; Fabrizio Veglia; Antonio L Bartorelli
Journal:  Int J Cardiol       Date:  2015-01-29       Impact factor: 4.164

3.  Preoperative statin therapy decreases risk of postoperative renal insufficiency.

Authors:  Salim S Virani; Vijay Nambi; Venkateshwar R Polsani; Vei-Vei Lee; MacArthur Elayda; Shun Kohsaka; Wei Pan; Ross M Reul; James M Wilson; Laura A Petersen; James T Willerson; Christie M Ballantyne
Journal:  Cardiovasc Ther       Date:  2010-04       Impact factor: 3.023

4.  Simvastatin ameliorates gentamicin-induced renal injury in rats.

Authors:  Mosadegh Jabbari; Zohreh Rostami; Aria Jenabi; Amir Bahrami; Ahmad Mooraki
Journal:  Saudi J Kidney Dis Transpl       Date:  2011-11

Review 5.  Preoperative Statin Therapy and Renal Outcomes After Cardiac Surgery: A Meta-analysis and Meta-regression of 59,771 Patients.

Authors:  Jiayang Wang; Chengxiong Gu; Mingxin Gao; Wenyuan Yu; Yang Yu
Journal:  Can J Cardiol       Date:  2015-02-28       Impact factor: 5.223

6.  KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.

Authors: 
Journal:  Am J Kidney Dis       Date:  2012-11       Impact factor: 8.860

7.  Effects of lowering LDL cholesterol on progression of kidney disease.

Authors:  Richard Haynes; David Lewis; Jonathan Emberson; Christina Reith; Lawrence Agodoa; Alan Cass; Jonathan C Craig; Dick de Zeeuw; Bo Feldt-Rasmussen; Bengt Fellström; Adeera Levin; David C Wheeler; Rob Walker; William G Herrington; Colin Baigent; Martin J Landray
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121

8.  Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?

Authors:  Vasilios G Athyros; Niki Katsiki; Konstantinos Tziomalos; Asterios Karagiannis
Journal:  Open Cardiovasc Med J       Date:  2011-12-02

9.  Pravastatin-induced rhabdomyolysis and purpura fulminans in a patient with chronic renal failure.

Authors:  Kazuya Kato; Kazuhiko Onodera; Yoshiaki Iwasaki; Minoru Matsuda; Takako Kawakami; Mineko Higuchi; Kimitaka Kato; Yurina Kato; Masahiko Taniguchi; Hiroyuki Furukawa
Journal:  Int J Surg Case Rep       Date:  2015-01-28

10.  Peri-operative fluid strategy and post-operative acute kidney injury in cardiac surgery patients: any role for pre-operative statin therapy?

Authors:  Patrick M Honore; Rita Jacobs; Inne Hendrickx; Elisabeth De Waele; Viola Van Gorp; Herbert D Spapen
Journal:  Crit Care       Date:  2015-12-29       Impact factor: 9.097

View more
  10 in total

1.  Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.

Authors:  Irem Karauzum; Kurtulus Karauzum; Burak Acar; Kaan Hanci; Halil Ibrahim Ulas Bildirici; Teoman Kilic; Ertan Ural
Journal:  J Transl Int Med       Date:  2021-07-09

Review 2.  Research Progress in Acute Hypertensive Renal Injury by "in Vivo Cryotechnique".

Authors:  Da Sun; Jiaojiao Wang; Li Yao; Zilong Li; Shinichi Ohno
Journal:  J Transl Int Med       Date:  2019-12-31

3.  Pathogenesis and Damage Targets of Hypertensive Kidney Injury.

Authors:  Da Sun; Jiaojiao Wang; Wansong Shao; Juan Wang; Li Yao; Zilong Li; Shinichi Ohno
Journal:  J Transl Int Med       Date:  2020-12-31

4.  Association of Prior to Intensive Care Unit Statin Use With Outcomes on Patients With Acute Kidney Injury.

Authors:  Boxiang Tu; Yuanjun Tang; Yi Cheng; Yuanyuan Yang; Cheng Wu; Xiaobin Liu; Di Qian; Zhansai Zhang; Yanfang Zhao; Yingyi Qin; Jia He
Journal:  Front Med (Lausanne)       Date:  2021-12-24

Review 5.  Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD.

Authors:  Roberto Pagliarini; Christine Podrini
Journal:  Front Med (Lausanne)       Date:  2021-11-24

6.  Effect of Roxadustat on the Pharmacokinetics of Simvastatin, Rosuvastatin, and Atorvastatin in Healthy Subjects: Results From 3 Phase 1, Open-Label, 1-Sequence, Crossover Studies.

Authors:  Dorien Groenendaal-van de Meent; Martin den Adel; Virginie Kerbusch; Jan van Dijk; Tomohisa Shibata; Kota Kato; Marloes Schaddelee
Journal:  Clin Pharmacol Drug Dev       Date:  2022-02-19

Review 7.  Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies.

Authors:  Magda Dubińska-Magiera; Marta Migocka-Patrzałek; Damian Lewandowski; Małgorzata Daczewska; Krzysztof Jagla
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 8.  Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components.

Authors:  Richard Myles Turner; Munir Pirmohamed
Journal:  J Clin Med       Date:  2019-12-20       Impact factor: 4.241

9.  Human podocyte injury in the early course of hypertensive renal injury.

Authors:  Da Sun; Jiao-Jiao Wang; Wei Wang; Juan Wang; Li-Ning Wang; Li Yao; Ying-Hui Sun; Zi-Long Li
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

Review 10.  Pharmacogenetics of Statin-Induced Myotoxicity.

Authors:  Ping Siu Kee; Paul Ken Leong Chin; Martin A Kennedy; Simran D S Maggo
Journal:  Front Genet       Date:  2020-10-16       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.